Skip to main content

Market Overview

UPDATE: SunTrust Robinson Humphrey Reiterates on Hologic as Deterioration Story Gains Momentum

Share:

In a report published Tuesday, SunTrust Robinson Humphrey analyst Amit Hazan reiterated a Reduce rating on Hologic (NASDAQ: HOLX), but lowered the price target from $17.00 to $15.00.

In the report, SunTrust Robinson Humphrey noted, “New guidance for FY14 reflects the reality of deteriorating end markets and only the beginning of significant margin pressure in the years ahead. Declining EBITDA and a two year delay in leverage target guidance are similarly of high concern. Hopes for a return to growth by FY15 look entirely unrealistic to us, and we lower our PT from $17 to $15 in order to reflect what we view as notably greater risk.”

Hologic closed on Monday at $22.90.

Latest Ratings for HOLX

DateFirmActionFromTo
Apr 2021Morgan StanleyMaintainsEqual-Weight
Apr 2021CitigroupMaintainsBuy
Apr 2021SVB LeerinkMaintainsOutperform

View More Analyst Ratings for HOLX
View the Latest Analyst Ratings

 

Related Articles (HOLX)

View Comments and Join the Discussion!

Posted-In: Amit Hazan SunTrust Robinson HumphreyAnalyst Color Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
PHXSeaport GlobalInitiates Coverage On
AFCGLake StreetInitiates Coverage On29.0
OSSNoble Capital MarketsUpgrades7.0
NCNOGabelli & Co.Upgrades
HAECJS SecuritiesUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com